Résztvevőt keres itt: OlaszországFázis nélkül
A ProspeCtive mUlticenteR Investigation on RENzar Stent Safety and Efficacy in the Treatment of Patients With Femoro-popliteal Disease in Tuscany (CURRENT Registry)
A legfontosabb adatok
- Ki végzi
- Azienda Ospedaliera Universitaria Senese
- Hol
- Siena (Olaszország)A helyszín megnézése
- Azonosító
- Állapot
- Toboroz
- Résztvevők
- 100 fő, tervezett
- Kezdés
- 2022. dec. 1.
- Várható befejezés
- 2026. dec. 1.
- A vizsgálat típusa
- Megfigyeléses
- A vizsgált kezelések
- Endovascular implantation of Renzan Stent
- A regiszteradat frissítve
- 2023. július 20.
Ki vehet részt
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.
The trial is looking for adults with narrowed or blocked arteries in the thigh or behind the knee (femoro-popliteal disease). They will be treated with the Renzan stent.
- Életkor
- 18 years or older
- Nem
- All sexes
- A betegség stádiuma
- Rutherford-Becker category 2 to 5, with a resting ankle-brachial index (ABI) of 0.9 or less. The common femoral, superficial femoral and/or popliteal artery must be more than 50% narrowed or fully blocked. The artery width must be between 4.0 mm and 8.0 mm. New narrowings and re-narrowings, also inside an old stent, can be treated. At least one open lower-leg artery below the narrowing is needed.
- Korábbi kezelés
- People cannot join if they had a heart artery procedure less than 90 days before, or one is planned within 30 days after. Clot-dissolving treatment of the target artery within 72 hours before is not allowed.
A részvétel fő kizáró okai
- Rutherford-Becker category 6 (tissue loss)
- Allergy or intolerance to nitinol (nickel titanium), or unable to take antiplatelet or blood-thinning drugs
- Dialysis within the previous 30 days, or stroke within the previous 90 days
- Pregnant or able to become pregnant
- Life expectancy of less than 1 year
A regiszter feltételei, szó szerint
Mind a 29 feltétel megnézéseKevesebb
Ki vehet részt
- Age ≥18 years
- Subject must provide written informed consent prior to the treatment of the target lesion
- Subject must be willing to comply with the specified follow-up evaluation schedule
- Subject with Rutherford-Becker clinical classification category 2 to 5, with a resting ankle-brachial index (ABI) ≤ 0.9
- Common femoral, superficial femoral and/or popliteal artery lesion with > 50% stenosis or total occlusion
- Stenotic or occluded lesion(s) within the same vessel with no length limits
- De novo or restenotic/occluded lesion(s) including in-stent restenosis, with reference vessel diameter (RVD) ≥ 4.0 mm and ≤ 8.0 mm by visual assessment and no length limits
- Multiple RENZAN stents could be deployed with a mandatory overlap of 0.5-1 cm
- A patent inflow artery free from the significant lesion (≥50% stenosis) as confirmed by angiography (treatment of target lesion acceptable after successful treatment of ipsilateral iliac lesions); Successful ipsilateral iliac artery treatment is defined as the attainment of residual diameter stenosis ≤30%, either with PTA or stenting
- The target lesion(s) can be successfully crossed with a guide wire and dilated up to 1:1 to the proposed stent to be implanted (as per the operator's assessment)
- At least one patent native outflow artery (anterior or posterior tibial or peroneal), free from significant (≥50%) stenosis (as confirmed by angiography), that has not previously been revascularized. The remaining outflow arteries requiring treatment during the same procedure may be treated
Ki nem vehet részt
- Use of drug-eluting balloon or stent
- Concomitant use of different stent platforms
- Subject with coronary intervention performed less than 90 days prior to or planned within 30 days after the treatment of the target lesion
- Any contraindication or known unresponsiveness to dual antiplatelet therapy (DAPT) or anticoagulation therapy
- Presence of acute thrombus prior to crossing the lesion
- Thrombolysis of the target vessel within 72 hours prior to the index procedure
- Thrombophlebitis or deep venous thrombus, within the previous 30 days
- Subject receiving dialysis within the previous 30 days
- Stroke within the previous 90 days
- Known allergies or intolerance to nitinol (nickel titanium)
- Subject has Rutherford-Becker classification category 6
- Treatment of lesions requiring the use of adjunctive debulking devices
- Inadequate vessel preparation not achieving a diameter of 1:1 to the stent to be implanted (with ≤20% residual stenosis, as per operator's assessment)
- Any significant vessel tortuosity or other parameters prohibiting access to the lesion and/or preventing the stent delivery
- Subject is pregnant or of childbearing potential
- Subject has a life expectancy of less than 1 year
- Subject is participating in an investigational study that has not reached the primary endpoint at the time of study screening
- Only one patent outflow artery, with significant stenosis (≥50%) (as confirmed by angiography)
Helyszínek itt: Olaszország
- University of SienaSiena, OlaszországContact: Edoardo Pasqui, MDRésztvevőt keres
A vizsgálatról
Mit akar kideríteni a vizsgálat
CURRENT Registry is a physician-initiated prospective, multicenter, post-market, single-arm study with a plan to include approximately 100 patients eligible to be treated with RenzanTM Peripheral Stent System.
A vizsgálat csoportja
- LEAD patients undergoing endovascular treatment with implantation of Renzan stent
Kezelés: Endovascular implantation of Renzan Stent
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- MI-összefoglaló
- A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
- A regiszteradat frissítve
- 2023. július 20.